about
Biologics in uveitisPulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literatureOccult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR AssayInternational and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24Behçet's disease and pregnancy.Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature.New insights into the pathogenesis of Behçet's disease.Cryoglobulinemia Vasculitis.CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.Mortality in Behçet's disease.The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humansBehcet's disease in Budd-Chiari syndrome.Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.Tuberculosis in HIV-infected patients: a comprehensive review.Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clonesBehçet's disease physiopathology: a contemporary review.Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation.Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study.CVID-associated TACI mutations affect autoreactive B cell selection and activation.Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.Ethnicity and association with disease manifestations and mortality in Behçet's disease.Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature.Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.Approaches to immunosuppression in Behçet's disease.Hepatitis C virus-induced vasculitis: therapeutic options.Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.Biotherapies in Behçet's disease.Systemic sclerosis and prevalence of monoclonal immunoglobulin.IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).
P50
Q26829826-4FD62F9A-6AF8-4C26-A15C-2227DFB1A3E7Q27008053-9F58806E-5BA0-451D-8437-C4A10BEEA8B4Q27486401-626669B5-0DDF-4F2C-8086-AF45F54B7B3CQ30234696-091E32A6-4912-48E0-8112-8BFCA742E79DQ33407192-DBD0E6B9-C130-4955-805B-1CA447A5C87BQ33408479-DB0CDE81-E92E-4092-A7BE-02EB09779EE6Q34045760-FD6CA2B5-1EB2-4D4A-A56F-1CC1B6DCA990Q34160074-B8B37C36-A6B5-46E3-9408-27AA30E29DFDQ34242907-364ED372-94DB-423F-AABF-7AD81B439886Q34470025-604A32A3-3F2A-4BE3-9E12-68F7959526CEQ34544033-C23E2892-59DC-4344-B8C7-A5146E45172AQ34619845-A536AD93-ADD3-4347-B674-BE006A6E946CQ35187072-9C3DE0A4-4C5F-42F3-9CE3-B7C01C855C78Q35360101-9289B112-9E7A-48BA-BC09-AA54E896B310Q35741844-AFDF08F3-13B0-48DF-80A9-D6E7FFECAC16Q35758273-0080F391-F2E2-4C92-8261-DDBC55FB972CQ35857842-074E5974-C3C7-4172-8EC7-3EF32A3582EEQ36009013-BEBBC378-99F2-42E9-A165-FD9B8C987A7AQ36026609-E1BAF6A8-79CF-49B8-ABA3-4ABFB84EB8BAQ36573124-BCD0F9CF-033F-4ABA-A7C1-67FFFBF05F59Q36633225-209015CC-D4D3-4F1B-BDDB-AB5429537922Q37003609-910D0076-5278-4A2C-B968-CA9AA94DA932Q37077898-8FEB9DF2-FFEB-408D-BAC5-621A869CFE6BQ37206886-C4172E20-5DFB-4CA7-8AE7-D658AA110780Q37696839-465008B4-3303-40FD-BB77-3E412BD9733CQ37702704-DB738AE4-4ABB-49B6-AE53-C3E68467CC9FQ37772959-7189A7B0-7868-44FC-A96F-750D08F14EF0Q37966614-7F26CC7A-5C7F-4C81-918B-0A7BE7EE588FQ37971304-DFA5F42D-045E-43FF-ABCA-6474FA6D9D72Q38055932-2F8259BB-DF27-42EE-B59C-FD553A24ACB1Q38085865-25AE9FFF-E250-48F7-B7C3-54E8C21F6759Q38087452-90FA080E-70CE-4A83-A85D-18AFDBD98F6FQ38119551-AE112B07-8F98-4AB4-B1DA-243E472348C1Q38127143-B8F3B6E4-66E9-453A-8C38-DBD424E89F62Q38162037-53E0346B-5B3D-4D60-9FED-976FBE3B61C4Q38182812-F77F533C-4654-4AE9-AA14-B871ABBAAFF2Q38242732-3FD6DEBB-BD91-4F22-9EC7-2C826AECFE81Q38300817-09009580-392F-41B9-8796-714B72C6FE7BQ38416654-30AC78CA-82E0-4FB0-9182-DBD2A85EB204Q38718798-C53F3F1A-622D-4750-8A6D-A16FFF186EC8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Saadoun
@ast
David Saadoun
@en
David Saadoun
@es
David Saadoun
@nl
type
label
David Saadoun
@ast
David Saadoun
@en
David Saadoun
@es
David Saadoun
@nl
prefLabel
David Saadoun
@ast
David Saadoun
@en
David Saadoun
@es
David Saadoun
@nl
P106
P1153
6602408836
P21
P31
P496
0000-0003-3628-9996